- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 285063, 7 pages
MicroRNA-Mediated Regulation in Biological Systems with Oscillatory Behavior
1Department of Mathematics, Shanghai University, Shanghai 200444, China
2Institute of Systems Biology, Shanghai University, Shanghai 200444, China
Received 30 April 2013; Revised 3 June 2013; Accepted 4 June 2013
Academic Editor: Tao Huang
Copyright © 2013 Zhiyong Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
As a class of small noncoding RNAs, microRNAs (miRNAs) regulate stability or translation of mRNA transcripts. Some reports bring new insights into possible roles of microRNAs in modulating cell cycle. In this paper, we focus on the mechanism and effectiveness of microRNA-mediated regulation in the cell cycle. We first describe two specific regulatory circuits that incorporate base-pairing microRNAs and show their fine-tuning roles in the modulation of periodic behavior. Furthermore, we analyze the effects of miR369-3 on the modulation of the cell cycle, confirming that miR369-3 plays a role in shortening the period of the cell cycle. These results are consistent with experimental observations.
MicroRNAs are single-stranded non-coding RNA molecules containing 2123-nucleotides. More and more works imply that microRNAs are involved in a series of important life processes, including early development, cell proliferation, differentiation, and apoptosis [1–11]. MicroRNAs act by base pairing with their target mRNAs and induce either translational repression or mRNA degradation through an RNA-induced silencing complex. Most microRNAs negatively regulate expression of their target genes. Since microRNA is a type of small molecules and needs not to be translated into proteins, it has an energy-saving advantage for the cell cycle regulation when compared to the regulation by proteins. In addition, its faster synthesis rate has more advantage in response to the changes in environment. These advantages mean that microRNA may play crucial roles in gene regulation.
A series of recent experiments show that microRNAs may play crucial roles in modulating periodic behaviors of biological systems, such as cell cycle and circadian rhythm [12–19]. Other reports indicate that microRNAs fine-tune oscillations of p53 in the process of tumor suppression [20–29]. However, all these findings have still been confined to experimental stage. The operating mechanism and potential implication of microRNA-mediated regulation in the modulation of periodic behavior are less clear and need to be further investigated.
In this study, we aim to explore the control mechanism and kinetic characteristics of microRNA-mediated regulation in the modulation of cell cycle. First, we model two specific network motifs, which have different periodic behaviors in the absence of microRNA, that is, oscillation generated by a Hopf bifurcation and relaxation oscillation. Furthermore, microRNA is incorporated into these two motifs, respectively. The dynamical analysis confirms that microRNA can regulate these two types of oscillations by shortening their periods. Then we study the microRNA regulation of a periodic phenomenon in biological system, that is, cell cycle. The results account for the roles of microRNA in the modulation of cell cycle observed in recent experiments.
2. MicroRNA Regulation of Two Motifs and Cell Cycle
2.1. Analysis of Motif I
The first motif without and with the regulation of microRNA is shown in Figure 1. In this motif, protein activates the transcription of gene , which in turn inhibits the transcription of gene , as shown in Figure 1(a).
With these assumptions, when the microRNA is not incorporated, we get a set of differential equations on the concentrations of the substrates, which describe the behaviors of the mRNA of gene , protein , and protein , as follows: where means the concentration of the substrate, and , , where , are hill coefficients.
When the microRNA regulation is incorporated into (1) (see Figure 1(b)), it becomes where is the synthesis rate of microRNA, is the degradation rate of microRNA, and is the associate rate of two RNAs.
Using the dimensionless variables scaled by , , , , , , , , , , and , , , we obtain two sets of equations as follows:
We can calculate the equilibriums by setting the right-hand sides of the equations equal to zero. Let the equilibrium be for (3). Linearizing (3) around the equilibrium results in the Jacobian matrix as follows: By simple calculation, its characteristic polynomial is derived as follows: Using Routh-Hurwitz criteria, we know that when the following condition is satisfied: a Hopf bifurcation occurs (and the right-hand side should be also larger than 0). In other words, when the left-hand side becomes less than the right-hand side in the above equation, oscillations will occur in (3).
By calculation, its characteristic polynomial is derived as follows: where , , and so on. Again, according to the Routh-Hurwitz criteria, we can obtain the condition of Hopf bifurcation as follows: that is, when the determinant becomes less than zero (and , , ), oscillations will occur in (4).
To investigate the dynamical properties of microRNA regulation in gene expression, we will next examine and compare the two models by computational analysis. To determine fundamental differences in these two models without and with microRNA regulation, it would be of interest to choose similar parameter values. We first choose values of parameters in (3), under which oscillations may occur. Then, under these fixed parameter values, other values of parameter in (4) are chosen so as to produce oscillations.
In Figure 2, the following parameter values in (3) are used: , , , , , , and . Other parameter values in (4) are , , and . It can be seen that after the incorporation of the microRNA regulation, the changes of the wave form and amplitude of the oscillation are slight. In contrast, the period is shortened evidently, which means that the fine-tuning of microRNA regulation in the oscillation is period shortening.
2.2. Analysis of Motif II
The second motif is similar to the first one except the positive autoregulation of protein , as shown in Figure 3.
When the microRNA is not incorporated, it has been discussed in . It was shown that relaxation oscillation could occur due to the existence of different time scales. Using their model, the system without microRNA regulation can be expressed as follows: where is the ratio of degradation rates between the two proteins and , , which means degradation rate of is much faster than that of . with means that the synthesis rate of protein is much slower than that of . Similar to the first motif, after the incorporation of miRNA regulation, the system can be rewritten as follows: where the first equation means that microRNA and protein codegrade nonlinearly at a rate besides their respective linear degradation. Similarly, the parameter values in (11) are chosen first so as to produce relaxation oscillations. Then other parameters in (12) are chosen. More exactly, parameter values are , , , , , , , and .
When the microRNA is not incorporated, relaxation oscillation occurs, as shown by the red line in Figure 4. Similar to the first motif, after the incorporation of the microRNA, the changes of the wave form and amplitude of the relaxation oscillation are slight. In contrast, the period is shortened significantly too, meaning that the main modulation of microRNA regulation in relaxation oscillation is also period shortening.
For both of the motifs, we get similar results; that is, the main modulation of microRNA regulation in periodic behavior is period shortening. In contrast, the types of oscillations, the wave forms, and amplitude of oscillations do not change significantly, thereby fine-tuning periodic behavior of biological systems.
2.3. Cell Cycle Regulation
Next, we study the roles of microRNA in modulation of cell cycle by incorporating a microRNA, that is, miR369-3, into a detailed model.
Recently, experimental report by Vasudevan et al. revealed that microRNA can up-regulate gene expression in G0/G1 arrest during mammalian cell cycle . In fact, they carried out a series of experiments by connecting a reporter mRNA to study miR369-3 expression in different conditions. These results show that miR369-3 promotes translation in G0/G1 arrest and suppresses translation in proliferating cells. It is equivalent to shortening the cell cycle process from the perspective of the entire cell cycle.
Many excellent theoretical models have been proposed to study the cell cycle [32–45]. The cell cycle consists of four phases: G1 phase, S phase, G2 phase, and M phase. Activation of the next stage is dependent on the normal completion of previous one. In , Novák and Tyson model the cell cycle as a two-steady-state process in which the two steady states are corresponding to G1 stage and S/G2/M stage, respectively. And the periodic switching between these two stable states is a result of the antagonism between CycB/Cdk1 and Cdh1/APC, which creates a G1 state with active Cdh1 and low CycB activity and an S/G2/M state with high CycB level and Cdh1 turned off.
Here we develop a computational model based on Tyson’s cell cycle model  to investigate the posttranscriptional role of microRNA in the modulation of the mammalian cell cycle. By using computational target prediction algorithm miRBase , we screen out all the potential target genes of miR369-3; all of them are not directly in the pathway given in Tyson’s model. However, among these potential target genes, Lox is found to inactivate CycD, an important gene in cell cycle during the period G0/G1 . Therefore, by introducing the new pathway miR369-3-Lox-CycD into the Tyson’s model, miR369-3 is incorporated into the cell cycle model.
Now, let us study the regulatory effects of microRNA in the modified model with kinetic analysis. The dynamical equations are different from Tyson’s model in two points: two new equations for Lox and miR369-3 and one additional term in equation for CycD to show the inactivation of CycD by Lox. Refer to following equations:
The new parameters , , , , , and are the production rate of miR369-3, linear degradation rate of miR369-3-association rate of miR369-3 with Lox, production rate of Lox, linear degradation rate of Lox, and inactivation rate of CycD by Lox, respectively.
Next, numerical simulations are conducted. In the simulations, all parameter values are the same as those used in Tyson’s model except the newly introduced ones. We run the simulation with a wide range of the new parameters, and similar results are derived. Here we show the results with the following set of parameters. Before the incorporation of the microRNA, the parameter values are taken as , , , , , and . After incorporating it, they are , , , , , and .
A simulation with and without microRNA regulation is presented in Figure 5, where concentrations of CycB and Cdh1 are shown. It can be seen that the incorporation of miR369-3 shortens the period of CycB with low expression representing the G1 phase and cells enter M phase earlier, which is in agreement with the experimental observations. We infer from the above results that miR369-3 exerts its regulation on cell cycle through the cell cycle period modulation. This founding is also similar to the results for the two motifs studied above.
The linear nature of the dependence of period on progressively varied is shown in Figure 6, which further reflects the roles played by the microRNA-mediated regulation. The period of oscillations decreases slightly but almost linearly with , meaning the fine-tuning of cell cycle by the miR369-3.
MicroRNA-mediated regulation has gained recent attention. With the accumulation of our knowledge about microRNA, more and more regulatory mechanisms will be revealed.
Recent experimental works have implicated that microRNAs may play a fine-tuning role in cell cycle regulation. However, most of them are based on experimental works, and the regulatory mechanisms are less clear theoretically and need to be further investigated.
Beginning with two motifs, we find that microRNAs do not significantly change the type of oscillations, including their wave forms and amplitudes, while the period changes significantly. It seems that such a fine-tuning is general for both motifs. With those results for simplified models, we further incorporate a microRNA, miR369-3, into a classical cell cycle model and study the microRNA regulatory effects and mechanisms for cell cycle. We found that the miR369-3 regulates cell cycle by slightly shortening the cell cycle period, thus accelerating the cell cycle, which is in agreement with experimental observations. With the accumulatation of experimental results related to microRNA regulation in cell cycle, we will further incorporate more microRNAs into cell cycle and investigate the overall regulatory effects of microRNAs regulation in the future, which may give deep insights into microRNA regulatory mechanisms in cell cycle.
Finally, it is worth noting that microRNA-mediated regulation has gained recent attention, and computational studies have revealed various regulatory properties unique to microRNAs. These findings will be helpful for our understating the operating mechanisms and biological implications of microRNA-mediated regulation. They also have great potential for biotechnological, therapeutic applications, and synthetic biology.
This work is supported by NSFC no. 10832006 and no. 11172158.
- A. Chakrabarty, S. Tranguch, T. Daikoku, K. Jensen, H. Furneaux, and S. K. Dey, “MicroRNA regulation of cyclooxygenase-2 during embryo implantation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 38, pp. 15144–15149, 2007.
- E. Wienholds, W. P. Kloosterman, E. Miska et al., “Cell biology: microRNA expression in zebrafish embryonic development,” Science, vol. 309, no. 5732, pp. 310–311, 2005.
- L. He, J. M. Thomson, M. T. Hemann et al., “A microRNA polycistron as a potential human oncogene,” Nature, vol. 435, no. 7043, pp. 828–833, 2005.
- A. M. Krichevsky, K.-C. Sonntag, O. Isacson, and K. S. Kosik, “Specific MicroRNAs modulate embryonic stem cell-derived neurogenesis,” Stem Cells, vol. 24, no. 4, pp. 857–864, 2006.
- J. Takamizawa, H. Konishi, K. Yanagisawa et al., “Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival,” Cancer Research, vol. 64, no. 11, pp. 3753–3756, 2004.
- M. Z. Michael, S. M. O'Connor, N. G. Van Holst Pellekaan, G. P. Young, and R. J. James, “Reduced accumulation of specific microRNAs in colorectal neoplasia,” Molecular Cancer Research, vol. 1, no. 12, pp. 882–891, 2003.
- H. Tagawa and M. Seto, “A microRNA cluster as a target of genomic amplification in malignant lymphoma ,” Leukemia, vol. 19, no. 11, pp. 2013–2016, 2005.
- R. Schickel, B. Boyerinas, S.-M. Park, and M. E. Peter, “MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death,” Oncogene, vol. 27, no. 45, pp. 5959–5974, 2008.
- H.-W. Hwang and J. T. Mendell, “MicroRNAs in cell proliferation, cell death, and tumorigenesis,” British Journal of Cancer, vol. 94, no. 6, pp. 776–780, 2006.
- H. R. Shcherbata, S. Hatfield, E. J. Ward, S. Reynolds, K. A. Fischer, and H. Ruohola-Baker, “The MicroRNA pathway plays a regulatory role in stem cell division,” Cell Cycle, vol. 5, no. 2, pp. 172–175, 2006.
- P. P. Medina and F. J. Slack, “microRNAs and cancer: an overview,” Cell Cycle, vol. 7, no. 16, pp. 2485–2492, 2008.
- M. Carleton, M. A. Cleary, and P. S. Linsley, “MicroRNAs and cell cycle regulation,” Cell Cycle, vol. 6, no. 17, pp. 2127–2132, 2007.
- S. A. Georges, M. C. Biery, S.-Y. Kim et al., “Coordinated regulation of cell cycle transcripts by p53-inducible microRNAs, miR-192 and miR-215,” Cancer Research, vol. 68, no. 24, pp. 10105–10112, 2008.
- S. D. Hatfield, H. R. Shcherbata, K. A. Fischer, K. Nakahara, R. W. Carthew, and H. Ruohola-Baker, “Stem cell division is regulated by the microRNA pathway,” Nature, vol. 435, no. 7044, pp. 974–978, 2005.
- J. A. Pulikkan, V. Dengler, P. S. Peramangalam et al., “Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia,” Blood, vol. 115, no. 9, pp. 1768–1778, 2010.
- Q. Liu, H. Fu, F. Sun et al., “miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes,” Nucleic Acids Research, vol. 36, no. 16, pp. 5391–5404, 2008.
- M. J. Bueno, I. P. De Castro, and M. Malumbres, “Control of cell proliferation pathways by microRNAs,” Cell Cycle, vol. 7, no. 20, pp. 3143–3148, 2008.
- R. R. Chivukula and J. T. Mendell, “Circular reasoning: microRNAs and cell-cycle control,” Trends in Biochemical Sciences, vol. 33, no. 10, pp. 474–481, 2008.
- Z. Yu, R. Baserga, L. Chen, C. Wang, M. P. Lisanti, and R. G. Pestell, “MicroRNA, cell cycle, and human breast cancer,” American Journal of Pathology, vol. 176, no. 3, pp. 1058–1064, 2010.
- G. T. Bommer, I. Gerin, Y. Feng et al., “p53-mediated activation of miRNA34 candidate tumor-suppressor genes,” Current Biology, vol. 17, no. 15, pp. 1298–1307, 2007.
- T.-C. Chang, D. Yu, Y.-S. Lee et al., “Widespread microRNA repression by Myc contributes to tumorigenesis,” Nature Genetics, vol. 40, no. 1, pp. 43–50, 2008.
- D. C. Corney, A. Flesken-Nikitin, A. K. Godwin, W. Wang, and A. Y. Nikitin, “MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth,” Cancer Research, vol. 67, no. 18, pp. 8433–8438, 2007.
- L. He, X. He, L. P. Lim et al., “A microRNA component of the p53 tumour suppressor network,” Nature, vol. 447, no. 7148, pp. 1130–1134, 2007.
- H. Hermeking, “The miR-34 family in cancer and apoptosis,” Cell Death and Differentiation, vol. 17, no. 2, pp. 193–199, 2010.
- V. Tarasov, P. Jung, B. Verdoodt et al., “Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G 1-arrest,” Cell Cycle, vol. 6, no. 13, pp. 1586–1593, 2007.
- H. Tazawa, N. Tsuchiya, M. Izumiya, and H. Nakagama, “Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 39, pp. 15472–15477, 2007.
- H. I. Suzuki and K. Miyazono, “Emerging complexity of microRNA generation cascades,” Journal of Biochemistry, vol. 149, no. 1, pp. 15–25, 2011.
- L. Santarpia, M. Nicoloso, and G. A. Calin, “MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype,” Endocrine-Related Cancer, vol. 17, no. 1, pp. F51–F75, 2010.
- H. Hermeking, “p53 enters the microRNA world,” Cancer Cell, vol. 12, no. 5, pp. 414–418, 2007.
- R. Guantes and J. F. Poyatos, “Dynamical principles of two-component genetic oscillators,” PLoS Computational Biology, vol. 2, no. 3, pp. 188–197, 2006.
- S. Vasudevan, Y. Tong, and J. A. Steitz, “Switching from repression to activation: microRNAs can up-regulate translation,” Science, vol. 318, no. 5858, pp. 1931–1934, 2007.
- B. Novák and J. J. Tyson, “A model for restriction point control of the mammalian cell cycle,” Journal of Theoretical Biology, vol. 230, no. 4, pp. 563–579, 2004.
- Z. Qu, W. R. MacLellan, and J. N. Weiss, “Dynamics of the cell cycle: checkpoints, sizers, and timers,” Biophysical Journal, vol. 85, no. 6, pp. 3600–3611, 2003.
- Z. Qu, J. N. Weiss, and W. R. MacLellan, “Regulation of the mammalian cell cycle: a model of the G1-to-S transition,” American Journal of Physiology, vol. 284, no. 2, pp. C349–C364, 2003.
- Z. Qu, J. N. Weiss, and W. R. MacLellan, “Coordination of cell growth and cell division: a mathematical modeling study,” Journal of Cell Science, vol. 117, no. 18, pp. 4199–4207, 2004.
- L. Yang, Z. Han, W. Robb MacLellan, J. N. Weiss, and Z. Qu, “Linking cell division to cell growth in a spatiotemporal model of the cell cycle,” Journal of Theoretical Biology, vol. 241, no. 1, pp. 120–133, 2006.
- Z. Han, L. Yang, W. R. MacLellan, J. N. Weiss, and Z. Qu, “Hysteresis and cell cycle transitions: how crucial is it?” Biophysical Journal, vol. 88, no. 3, pp. 1626–1634, 2005.
- B. Pfeuty, T. David-Pfeuty, and K. Kaneko, “Underlying principles of cell fate determination during G1 phase of the mammalian cell cycle,” Cell Cycle, vol. 7, no. 20, pp. 3246–3257, 2008.
- B. Pfeuty, “Strategic cell-cycle regulatory features that provide mammalian cells with tunable G1 length and reversible G1 arrest,” PLoS ONE, vol. 7, no. 4, Article ID e35291, 2012.
- J. J. Tyson, A. Csikasz-Nagy, and B. Novak, “The dynamics of cell cycle regulation,” BioEssays, vol. 24, no. 12, pp. 1095–1109, 2002.
- A. Csikász-Nagy, D. Battogtokh, K. C. Chen, B. Novák, and J. J. Tyson, “Analysis of a generic model of eukaryotic cell-cycle regulation,” Biophysical Journal, vol. 90, no. 12, pp. 4361–4379, 2006.
- C. Gérard and A. Goldbeter, “Temporal self-organization of the cyclin/Cdk network driving the mammalian cell cycle,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 51, pp. 21643–21648, 2009.
- C. Gérard and A. Goldbeter, “From simple to complex patterns of oscillatory behavior in a model for the mammalian cell cycle containing multiple oscillatory circuits,” Chaos, vol. 20, no. 4, Article ID 045109, 2010.
- C. Grard and A. Goldbeter, “A skeleton model for the network of cyclin-dependent kinases driving the mammalian cell cycle,” Interface Focus, vol. 1, no. 1, pp. 24–35, 2011.
- A. Altinok, D. Gonze, and F. Levi, “An automaton model for the cell cycle,” Interface Focus, vol. 1, no. 1, pp. 36–47, 2011.
- G. P. Pidgeon, M. Kandouz, A. Meram, and K. V. Honn, “Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells,” Cancer Research, vol. 62, no. 9, pp. 2721–2727, 2002.